# Google Teams Up with Masimo for Exclusive Health Features on Wear OS
In a groundbreaking initiative to improve health monitoring capabilities on Wear OS smartwatches, **Google** has joined forces with **Masimo**, a front-runner in medical technology, to introduce sophisticated health features to its wearable platform. This alliance, which includes **Qualcomm** as well, seeks to establish a reference model that will facilitate the creation of health-centric smartwatches, providing users with more precise and dependable health information.
## Essential Information
– **Google, Masimo, and Qualcomm** are collaborating to embed high-end health tracking functionalities into Wear OS smartwatches.
– Google has acquired a license for **Masimo’s blood oxygen monitoring technology** and other health-focused features for Wear OS devices.
– Masimo’s platform is engineered to function flawlessly with Wear OS, guaranteeing precise health tracking and effortless syncing with Android gadgets.
– Even though smartwatch makers maintain authority over their devices’ design and interface, Masimo will manage the underlying technology, such as biosensors and testing.
## A New Chapter for Wear OS Health Monitoring
The collaboration between Google and Masimo represents a major advancement in the progression of health monitoring on Wear OS. Masimo, known for its innovative medical technology, has created a reference platform that will enable smartwatch developers to incorporate cutting-edge health features with greater ease. This platform consists of **biosensing technology** that delivers precise health data, including blood oxygen levels, heart rates, and other essential metrics.
### Masimo’s Proficiency in Health Technology
Masimo has deep roots in the health technology field. The company boasts a long track record of producing medical-grade devices and technologies, especially in **blood oxygen monitoring**. Previously, Masimo was engaged in a legal battle with **Apple**, accusing the tech giant of utilizing its blood oxygen monitoring technology unlawfully within the Apple Watch. This dispute resulted in a temporary suspension of Apple Watch sales, leading Apple to eventually disable the blood oxygen feature across all models to resolve the conflict.
Now, Masimo has shifted its focus to Google’s Wear OS platform, offering its expertise in health monitoring to enhance Google’s competitiveness in the increasingly saturated wearables market.
## Qualcomm’s Contribution
**Qualcomm**, a major player in the semiconductor sector, is also a part of this initiative. The company’s **Snapdragon chips** are commonly utilized in smartwatches and other wearables, and Qualcomm’s participation guarantees that the new health features will be fine-tuned for optimal performance and efficiency. Through close cooperation, Google, Masimo, and Qualcomm aim to deliver a unified experience for users, supplying precise health data and seamless integration with Android smartphones.
## Advantages for Consumers
A key benefit of this partnership is the improved accessibility of advanced health tracking features for consumers. Presently, health monitoring capabilities differ significantly among various smartwatch models and price points. While some devices feature high-end functionalities like blood oxygen monitoring and ECG (electrocardiogram) readings, others may compromise on quality to lower costs, resulting in less reliable data.
With Masimo’s technology incorporated into Wear OS, consumers can anticipate **more reliable and precise health monitoring** across a broader selection of devices. This is particularly crucial for individuals who depend on their smartwatches to track essential health metrics, including those with chronic illnesses or fitness enthusiasts.
## Manufacturer Customization
Despite Masimo’s role in the internal technology, smartwatch makers will continue to have the flexibility to shape the aesthetics and user experiences of their devices. This allows for a standardized and dependable health tracking system while enabling manufacturers to distinguish their products through design, materials, and user experience.
This adaptability is vital in the competitive smartwatch landscape, where brands like **Samsung**, **Fossil**, and **Garmin** continually strive for consumer interest with distinctive designs and features. By allowing manufacturers to retain control over the appearance and functionality of their devices, Google and Masimo are ensuring that the Wear OS ecosystem remains vibrant and competitive.
## A Boost for Wear OS
Google’s alliance with Masimo is part of a larger plan to bolster Wear OS as a platform. Although Wear OS has always been a competitor to Apple’s **watchOS**, it has frequently fallen short in terms of features and overall user experience. However, with the advent of **Wear OS 5** and the incorporation of Masimo’s cutting-edge health tracking technologies, Google is positioning itself as a serious rival in the wearables market.
Additionally, this collaboration emphasizes Google’s dedication to **health and wellness**, an area of increasing focus for tech companies as consumers become more health-oriented. By offering top-tier health features, Google is enhancing the attraction of Wear OS smartwatches while also tapping into the profitable market for health-centric wearables.
## In Conclusion
The collaboration between Google and Masimo signifies a monumental advancement for health tracking on Wear OS smartwatches. By licensing Masimo’s sophisticated blood oxygen monitoring technology and other health functionalities, Google ensures that Wear OS devices provide **more precise and reliable health data**.
